Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy-Reference-Cited by-同舟云学术

Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy

Published:2019-01-15 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Tanaka Shota,Luk Samantha,Kiyokawa Juri,Onozato Maristela L.,Iafrate A. John,Shah Khalid,Martuza Robert L.,Rabkin Samuel D.,Batchelor Tracy T.,Cahill Daniel P.,Chi Andrew S.,Wakimoto Hiroaki

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-37437-2.pdf

Reference44 articles.

1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine 352, 987–996 (2005).

2. Tanaka, S., Louis, D. N., Curry, W. T., Batchelor, T. T. & Dietrich, J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol 10, 14–26, https://doi.org/10.1038/nrclinonc.2012.204 (2013).

3. Bigner, S. H. et al. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 50, 8017–8022 (1990).

4. Sugawa, N., Ekstrand, A. J., James, C. D. & Collins, V. P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87, 8602–8606 (1990).

5. Gonzales, A. J. et al. Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor. Mol Cancer Ther 7, 1880–1889, https://doi.org/10.1158/1535-7163.MCT-07-2232 (2008).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells;Biomedicine & Pharmacotherapy;2024-07

2. Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?;Neuro-Oncology;2023-11-23

3. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells;Frontiers in Cellular and Infection Microbiology;2023-05-31

4. Preclinical modeling of lower-grade gliomas;Frontiers in Oncology;2023-03-27

5. Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling;Journal of Nanobiotechnology;2023-02-08